INNO BIOLOGICS specialises in mammalian cell culture technology and operates the state-of-the-art cGMP facility for the production of biopharmaceuticals. The facility is built to comply with European Medical Agency (EMEA) and United States Food and Drug Administration (FDA) regulatory requirements.
We offer complete services from upstream to downstream operation for the development of your therapeutic proteins. Our reliable, rapid and cost effective services will reduce risks, cost and time investment. This will ensure our customers will get the product candidates into the market in line with their vision and strategy.